scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
2.480
+0.040 (1.64%)
At close: May 12, 2025, 4:00 PM
2.470
-0.010 (-0.40%)
After-hours: May 12, 2025, 7:15 PM EDT
scPharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for scPharmaceuticals stock have an average target of 14, with a low estimate of 12 and a high estimate of 18. The average target predicts an increase of 464.52% from the current stock price of 2.48.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 20, 2025.
Analyst Ratings
The average analyst rating for scPharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $20 → $12 | Strong Buy | Maintains | $20 → $12 | +383.87% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +625.81% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +625.81% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +625.81% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +625.81% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
76.05M
from 36.33M
Increased by 109.32%
Revenue Next Year
134.57M
from 76.05M
Increased by 76.95%
EPS This Year
-1.00
from -1.91
EPS Next Year
-0.21
from -1.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 84.0M | 160.4M | 262.5M | ||
| Avg | 76.1M | 134.6M | 204.2M | ||
| Low | 68.3M | 109.0M | 159.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 131.2% | 111.0% | 95.1% | ||
| Avg | 109.3% | 76.9% | 51.8% | ||
| Low | 88.0% | 43.3% | 18.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.74 | 0.58 | 1.58 | ||
| Avg | -1.00 | -0.21 | 0.66 | ||
| Low | -1.22 | -0.64 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.